))
Hospice Pharmacy Need to Know
Manage episode 394186268 series 3547878
Content provided by Chris Comeaux. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chris Comeaux or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this podcast, Chris interviews Mary Mihalyo, CEO & Co-founder of Delta Care RX. Mary has a rich history of teaching and helping to improve the care delivery of the hospice and palliative care segment via pharmacotherapy management, options and expertise.
Mary through her expertise and then later through helping to co-found Delta Care RX has helped hospice and palliative care organizations since 1999 save dollars and at the same time improve quality hospice care. This win-win has enabled hospice programs to reinvest in their missions in significant ways. Mary also shares some future innovations in the pharmacotherapy area that we might look forward to.
A great quote from the podcast from Mary, “The more things change in hospice pharmaceutical care the more they stay the same. Many of the national medication related issues we are dealing with today are the same as what we dealt with decades ago. Hospices with a solid pharmaceutical care infrastructure likely fare better.”
This is a great listen for staff, leaders, and Board’s of hospice and palliative care organizations. Join us, this is timely and relevant.
"It is not immoral or unethical to think about the cost of therapy. In fact, the cost of therapy should be recognized regardless of the environment of care." – Mary Mihalyo
Guest: Mary Mihalyo, PharmD, BCPS; CEO & Co-founder of Delta Care RX
Host: Chris Comeaux, President / CEO of TCN
www.teleioscn.org
Teleios Collaborative Network / https://www.teleioscn.org/tcntalkspodcast
87 episodes
Share
